1. Bao, Qichao, Kumar, Anil, Wu, Daqing, Zhou, Jia. 2024. Targeting EED as a key PRC2 complex mediator toward novel epigenetic therapeutics. In Drug discovery today, 29, 103986. doi:10.1016/j.drudis.2024.103986. https://pubmed.ncbi.nlm.nih.gov/38642703/
2. Cook, Nicholas, Chen, Jianping, Zhou, Jia, Wu, Daqing. . Embryonic Ectoderm Development (EED) as a Novel Target for Cancer Treatment. In Current topics in medicinal chemistry, 21, 2771-2777. doi:10.2174/1568026621666210920154942. https://pubmed.ncbi.nlm.nih.gov/34544341/
3. Wang, Ying-Ying, Deng, Yu-Sen, Dai, Shang-Kun, Liu, Chang-Mei, Teng, Zhao-Qian. 2022. Loss of microglial EED impairs synapse density, learning, and memory. In Molecular psychiatry, 27, 2999-3009. doi:10.1038/s41380-022-01576-w. https://pubmed.ncbi.nlm.nih.gov/35484239/
4. Zhao, Yuan, Guan, Yuan-Yuan, Zhao, Fang, Duan, Ying-Chao, Zhou, Xiao-Li. 2022. Recent strategies targeting Embryonic Ectoderm Development (EED) for cancer therapy: Allosteric inhibitors, PPI inhibitors, and PROTACs. In European journal of medicinal chemistry, 231, 114144. doi:10.1016/j.ejmech.2022.114144. https://pubmed.ncbi.nlm.nih.gov/35093670/
5. Liu, Pei-Pei, Han, Xiao, Li, Xiao, Yang, Yun-Gui, Liu, Chang-Mei. 2024. An EED/PRC2-H19 Loop Regulates Cerebellar Development. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 12, e2403591. doi:10.1002/advs.202403591. https://pubmed.ncbi.nlm.nih.gov/39498824/